首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷手術用器具內視鏡檢查設備

市場調查報告書

商品編碼

1736694

按產品類型、性別、血管類型、應用、區域範圍和預測分類的內視鏡血管採集系統的全球市場規模

Global Endoscopic Vessel Harvesting Systems Market Size By Product, By Usability, By Vessel-Type, By Application, By Geographic Scope And Forecast

出版日期: 2025年05月06日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

內視鏡血管採集系統的市場規模及預測

2024 年內視鏡血管採集系統市場規模價值 4,802.8 億美元，預計到 2032 年將達到 6,422.8 億美元，預測期內（2026-2032 年）的複合年成長率為 3.70%。

內視鏡血管採集系統市場促進因素

內視鏡血管採集系統市場的市場促進因素可能受到多種因素的影響，其中包括：

心血管疾病發生率不斷上升。內視鏡血管採集裝置在世界各地越來越受歡迎，部分原因是心血管疾病的發生率不斷上升。冠狀動脈繞道手術手術（CABG）在很大程度上依賴這些系統來治療冠狀動脈疾病。

內視鏡方法的改進：隨著內視鏡方法和技術的不斷改進，內視鏡血管採集如今更加安全、創傷更小、更有效。這促使醫護人員開始使用內視鏡血管採集技術。

微創手術：微創手術技術因其許多優勢，包括住院時間短、恢復更快、術後併發症更少，越來越受到病人和醫師的青睞。用於血管採集的內視鏡系統使心血管手術的微創操作更加便捷。隨著全球人口老化，需要接受心血管手術的人數也增加。內視鏡血管採集是創傷性最小的手術之一，尤其有利於併發症較多的老年患者。

擴大醫療保健基礎設施：由於新興國家醫療保健基礎設施的擴大，內視鏡血管採集系統市場正在擴大，這使得人們更容易獲得尖端手術技術和設備。

成本效益：內視鏡取血管手術裝置在初始投資後，可以透過減少住院時間、降低併發症發生率並加快患者復原來節省長期成本。醫療機構熱衷於投資這些系統的主要原因之一是其成本效益。

監管支援：各個領域對內視鏡血管採集系統的有利法規和核准透過確保這些設備的安全性和有效性來推動市場成長，從而增強了醫療保健提供者對其採用的信心。

改進技術：吸引尋求心血管手術最新方法的醫療保健專業人員和患者，旨在提高內視鏡血管採集設備的有效性、安全性和易用性的持續技術改進將推動市場擴張。

限制內視鏡血管採集系統市場的因素

內視鏡取血管手術系統市場面臨多種限制與挑戰，包括：

昂貴：內視鏡血管採集設備的初始和後續操作成本高昂。對於規模較小的醫療機構或融資緊張的機構來說，這可能是一個重大障礙。

報銷有限：內視鏡取血管手術的費用可能無法完全由保險報銷政策覆蓋，從而降低了醫療專業人員使用該技術的動機。

技術複雜性：熟練內視鏡取血管手術技術可能需要特殊的訓練和專業知識。因此，具備相關資格的醫療專業人員可能較少。

問題風險：內視鏡取血管手術與其他外科手術一樣，有同樣的問題風險，包括出血、感染和潛在的組織損傷。這些風險可能會導致一些醫護人員選擇不使用這些系統。

抵制改變：外科醫生可能不願意使用新的工具和方法，特別是如果他們長期以來一直使用傳統方法成功地獲取血管。

監管障礙：獲得新型內視鏡取血管手術設備的監管批准可能耗時且成本高昂，這可能會延遲市場進入並提高生產商的價格。

替代方案的可用性：由於熟悉或感知的有效性，某些外科醫生或醫療機構可能更喜歡傳統的開放式血管採集方法而不是內視鏡系統，這可能會限制採用。

病患選擇：由於血管品質、病患解剖結構和潛在疾病的存在，並非所有病患都適合進行內視鏡血管採集，從而限制了這些系統的市場。

基礎設施需求：一些醫療機構可能沒有內視鏡取血管手術系統所需的專用設備或手術室，在這種情況下可能需要安裝該系統。

長期耐用性和有效性：與更傳統的技術相比，內視鏡取血管手術的長期耐用性和有效性仍值得懷疑，這可能會影響患者和醫療保健專業人員的採用率。

內視鏡血管採集系統市場區隔分析

全球內視鏡血管採集系統市場根據產品、可用性、血管類型、應用和地區進行細分。

內視鏡血管採集系統市場（依產品分類）

EVH 系統
內視鏡檢查
配件

根據產品，市場細分為EVH系統、內視鏡和配件。由於微創血管採集技術的應用日益廣泛，且這些產品為一次性產品，EVH系統預計將佔據最大的市場佔有率，並在整個預測期內保持最快的成長速度。

內視鏡血管採集系統市場（依使用者性別分類）

一次性的
可重複使用的

根據可用性，市場分為拋棄式和可重複使用兩類。一次性產品佔據了大部分市場佔有率，預計在預測期內將以最快的速度成長，因為一次性設備因其優於可重複使用設備的優勢而需求不斷成長。

內視鏡血管採集系統市場（依血管類型分類）

隱靜脈
橈動脈

根據血管類型，市場分為隱靜脈和橈動脈。由於隱靜脈在傷口併發症、減輕疼痛和美觀方面的優勢，預計預測期內隱靜脈段將以最快的速度成長。

內視鏡血管採集系統市場（依應用）

冠狀動脈疾病
周邊動脈疾病

根據應用，市場分為冠狀動脈疾病和周邊動脈疾病。由於心血管疾病盛行率上升和老年人口成長，預計冠狀動脈疾病領域將在整個預測期內以最快的速度成長。

內視鏡血管採集系統市場（按地區）

北美洲
歐洲
亞太地區
其他
根據區域分析，全球內視鏡血管採集系統市場分為北美、歐洲、亞太地區和亞太其他地區。目前，北美佔據全球市場主導地位，其次是歐洲，原因是這些地區久坐的生活方式導致冠狀動脈疾病發生率高，且各種微創冠狀動脈繞道手術（CABG）較為普及。隨著亞太國家人均收入的提高和醫療旅遊業的蓬勃發展，預計亞太地區的全球市場將快速成長。

主要參與企業

內視鏡血管採集系統市場的主要參與企業有：
Bausch Health
Sun Pharmaceutical Industries Ltd
Novartis AG
Teva Pharmaceutical Industries Ltd
Roche
Teva
Abbott
Johnson & Johnson
Novo Nordisk
Arena Pharmaceuticals
Akrimax Pharmaceuticals.
Sorin Group

Growing Incidence of Cardiovascular disorders: Endoscopic vessel harvesting devices are becoming more and more popular worldwide, partly due to the growing prevalence of cardiovascular disorders. In order to treat coronary artery disease, coronary artery bypass graft (CABG) procedures depend heavily on these systems.

Improvements in Endoscopic methods: Endoscopic vascular harvesting is now safer, less intrusive, and more effective thanks to ongoing improvements in endoscopic methods and technologies. This promotes healthcare providers to use endoscopic vessel harvesting technologies.

Minimally Invasive Surgery: Because of its many advantages, including shorter hospital stays, quicker recovery periods, and fewer post-operative complications, minimally invasive surgical methods are becoming more and more popular among both patients and doctors. Endoscopic systems for harvesting vessels allow for less intrusive techniques in heart surgery.Population Aging: As people get older worldwide, there is a rise in the number of people who need heart surgery. Endoscopic vascular harvesting is one of the less invasive techniques that is especially beneficial for older patients because these patients frequently have comorbidities.

Healthcare Infrastructure expansion: The market for endoscopic vessel harvesting systems is expanding as a result of the expansion of healthcare infrastructure in emerging economies. There is more access to cutting-edge surgical methods and equipment as these areas develop their healthcare infrastructure.

Cost-Effectiveness: Endoscopic vessel harvesting devices can save money in the long run by lowering hospital stays, complication rates, and hastening patient recovery, even after they need an initial investment. One of the main reasons healthcare facilities want to invest in these systems is their cost-effectiveness.

Regulatory Support: By guaranteeing the safety and effectiveness of these devices, favorable regulatory regulations and approvals for endoscopic vessel harvesting systems across different areas foster market growth and increase healthcare providers' trust in implementing them.

Technological improvements: By drawing in medical professionals and patients who are looking for the newest methods in heart surgery, ongoing technological improvements targeted at enhancing the effectiveness, safety, and usability of endoscopic vascular harvesting devices propel market expansion.

Endoscopic Vessel Harvesting Systems Market Restraints

Several factors can act as restraints or challenges for the Endoscopic Vessel Harvesting Systems Market. These may include:

Expensive: Endoscopic vessel harvesting devices can be costly to operate, both initially and continuously. For smaller healthcare facilities or those with tighter funds, this can be a major obstacle.

Limited Reimbursement: Policies for reimbursement might not completely cover the expense of endoscopic vascular harvesting operations, which would discourage healthcare professionals from using them.

Technical Complexity: It may need specific training and expertise to become proficient in the methods needed for endoscopic vascular harvesting. As a result, there may be fewer medical personnel qualified to carry out these treatments.

Risk of problems: Endoscopic vascular harvesting carries the same risks of problems as any surgical surgery, including the possibility of bleeding, infection, and tissue injury. A few healthcare professionals might decide not to use these systems because of these hazards.

Opposition to Change: Surgeons may be reluctant to use new tools or methods, particularly if they have been successfully harvesting vessels using conventional methods for a long time.

Regulatory obstacles: Getting regulatory permission for novel endoscopic vessel harvesting devices can be a time-consuming and expensive procedure that might cause delays in entering the market or raise prices for producers.

Availability of Alternatives: Due to familiarity or perceived efficacy, certain surgeons or healthcare facilities may still favor traditional open vessel harvesting methods over endoscopic systems, which could hold down their adoption.

Patient Selection: Depending on the quality of the vessel, the anatomy of the patient, and any underlying medical issues, not every patient may be a good candidate for endoscopic vascular harvesting. As a result, the market for these systems is limited.

Infrastructure Requirements: Some healthcare facilities may not have the specialized equipment or operating rooms needed for endoscopic vessel harvesting systems, which could make them necessary.

Long-term Durability and Efficacy: Patients' and healthcare professionals' adoption rates may be impacted by doubts over the long-term durability and efficacy of endoscopic vessel harvesting in comparison to conventional techniques.

Endoscopic Vessel Harvesting Systems Market Segmentation Analysis

The Global Endoscopic Vessel Harvesting Systems Market is segmented on the basis of Product, Usability, Vessel-Type, Application, And Geography.

Endoscopic Vessel Harvesting Systems Market, By Product

EVH Systems
Endoscopes
Accessories

Based on Product, The market is bifurcated into EVH Systems, Endoscopes, and Accessories. The EVH systems segment had the biggest market share, and it is predicted to grow at the fastest rate throughout the forecast period. This is due to the increasing use of less invasive techniques for vessel harvesting as well as the disposable nature of these products.

Endoscopic Vessel Harvesting Systems Market, By Usability

Disposable
Reusable

Based on Usability, The market is bifurcated into Disposable, and Reusable. The disposable segment accounted for the majority of the market. This category is also predicted to grow at the fastest rate over the forecast period, owing to a growing demand for disposable devices over reusable devices due to the benefits they offer.

Endoscopic Vessel Harvesting Systems Market, By Vessel-Type

Saphenous Vein
Radial Artery

Based on Vessel-Type, The market is bifurcated into Saphenous Vein and Radial Artery. During the forecast period, the saphenous vein segment is predicted to grow at the fastest rate. This is owing to the benefits of the saphenous vein in terms of wound complications, pain reduction, and aesthetics.

Endoscopic Vessel Harvesting Systems Market, By Application

Coronary Artery Disease
Peripheral Artery Disease

Based on Application, The market is bifurcated into Coronary Artery Disease and Peripheral Artery Disease. Because of the rising prevalence of cardiovascular illnesses and the growing geriatric population, the coronary artery disease sector is predicted to grow at the fastest rate throughout the forecast period.

Endoscopic Vessel Harvesting Systems Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Geography Analysis, The Global Endoscopic Vessel Harvesting Systems Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is now dominating the global market, followed by Europe because of the high incidence of coronary disease owing to sedentary lifestyle patterns adopted in these regions and the availability of all forms of minimally invasive CABG operations. Owing to the rise in per capita income in Asian countries and the growing medical tourism sector, the global market in the Asia Pacific is predicted to rise at a rapid pace.

Key Players

The major players in the Endoscopic Vessel Harvesting Systems Market are:
Bausch Health
Sun Pharmaceutical Industries Ltd
Novartis AG
Teva Pharmaceutical Industries Ltd
Roche
Teva
Abbott
Johnson & Johnson
Novo Nordisk
Arena Pharmaceuticals
Akrimax Pharmaceuticals.
Sorin Group

1 INTRODUCTION OF GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY PRODUCT

5.1 Overview
5.2 EVH Systems
5.3 Endoscopes
5.4 Accessories

6 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY USABILITY

6.1 Overview
6.2 Disposable
6.3 Reusable

7 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY VESSEL-TYPE

7.1 Overview
7.2 Saphenous Vein
7.3 Radial Artery

8 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY APPLICATION

8.1 Overview
8.2 Coronary Artery Disease
8.3 Peripheral Artery Disease

9 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET, BY GEOGRAPHY

9.1 Overview
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 U.K.
- 9.3.3 France
- 9.3.4 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Rest of Asia Pacific
9.5 Rest of the World
- 9.5.1 Latin America
- 9.5.2 Middle East & Africa

10 GLOBAL ENDOSCOPIC VESSEL HARVESTING SYSTEMS MARKET COMPETITIVE LANDSCAPE

10.1 Overview
10.2 Company Market Ranking
10.3 Key Development Strategies

11 COMPANY PROFILES

11.1 Getinge
- 11.1.1 Overview
- 11.1.2 Financial Performance
- 11.1.3 Product Outlook
- 11.1.4 Key Developments
11.2 MAQUET Holdings
- 11.2.1 Overview
- 11.2.2 Financial Performance
- 11.2.3 Product Outlook
- 11.2.4 Key Developments
11.3 Med Europe S.r.l.
- 11.3.1 Overview
- 11.3.2 Financial Performance
- 11.3.3 Product Outlook
- 11.3.4 Key Developments
11.4 Terumo
- 11.4.1 Overview
- 11.4.2 Financial Performance
- 11.4.3 Product Outlook
- 11.4.4 Key Developments
11.5 Saphena Medical
- 11.5.1 Overview
- 11.5.2 Financial Performance
- 11.5.3 Product Outlook
- 11.5.4 Key Developments
11.6 KARL STORZ
- 11.6.1 Overview
- 11.6.2 Financial Performance
- 11.6.3 Product Outlook
- 11.6.4 Key Developments
11.7 Cardio Medical
- 11.7.1 Overview
- 11.7.2 Financial Performance
- 11.7.3 Product Outlook
- 11.7.4 Key Developments
11.8 Medical Instruments Spa
- 11.8.1 Overview
- 11.8.2 Financial Performance
- 11.8.3 Product Outlook
- 11.8.4 Key Developments
11.9 LivaNova
- 11.9.1 Overview
- 11.9.2 Financial Performance
- 11.9.3 Product Outlook
- 11.9.4 Key Developments